Llwytho...
CA4-05: Electronic Health Record Phenotyping to Define Rate of Extreme Weight Gain Associated with the Use of 2nd/3rd Generation Antipsychotic Medications
BACKGROUND/AIMS: Weight gain is an undesirable side effect of treatment with 2nd/3rd generation antipsychotic drugs which may have genetic determinants. A number of candidate genes have been analyzed but no genome-wide association studies (GWAS) have yet been reported. The purpose of this study was...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Marshfield Clinic
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421302/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.ca4-05 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|